Dr Robert M Lembo Md - 10016 New York City, NY

Business Name: Dr Robert M Lembo Md
Categorized In: Doctors
Address: 462 1st Avenue, New York City, NY 10016
Phone Number: (212) 263-6425
Contact Person: Robert M Lembo
NAICS Code: 621111
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 2011
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Andrew M Milano - New York City, NY 10016
Aubrey C Galloway Surgeon - New York City, NY 10016
Banta Erin M MD - New York City, NY 10016
Allen Sybil MD - New York City, NY 10016
Alonso Carmen M MD - New York City, NY 10016
Barkan Liana H MD - New York City, NY 10016
Amorosi Edward L MD - New York City, NY 10016
Auslender Marcelo J MD - New York City, NY 10016
Aguirre Ameth MD - New York City, NY 10016
Allergy Asthma Care Mnhttn - New York City, NY 10016
Baharestani Samuel MD - New York City, NY 10016
Akowuah Kwame S MD - New York City, NY 10016
Ballas Marc S MD - New York City, NY 10016
Archibald Luke J MD - New York City, NY 10016
Anbarasan Deepti MD - New York City, NY 10016
6C Surgical Assoc - New York City, NY 10016
Allergist on Call - New York City, NY 10016
Advanced Eyecare - New York City, NY 10016
Bansal Amit K DO - New York City, NY 10016
Anthony Dibiase - New York City, NY 10016

Dr Robert M Lembo Md provides professional Doctors from its single location at the coordinates 40.739659,-73.976311.

The company offers B2C variables under the SIC code 8011 and NAICS code 621111, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2011, the company can now be visited at 462 1st Avenue, New York City, New York 10016 or contacted through representative Robert M Lembo at (212) 263-6425.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Dr Robert M Lembo Md through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.